From Our Partners
Sunday, July 3, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Indo-U.S. Vaccine Action Program Small Research Grants

by Global Biodefense Staff
April 10, 2013

Influenza and Infectious Disease Research ProgramsThe National Institute of Allergy and Infectious Diseases (NIAID) has issued a grant opportunity to fund research activities leading to the development of new and improved vaccines and related products and technologies to combat infectious diseases of importance in India, the U.S., the South Asian region and globally. 

Applications are encouraged from organizations that propose to conduct vaccine-related research through U.S.-Indo collaborations on the following: dengue, influenza (including avian influenza), malaria, enteric diseases, HIV/AIDS, and tuberculosis.  Basic, translational, clinical, or epidemiological vaccine research may be proposed.

Special initiatives have been undertaken over the years in an effort to advance cooperation with India more rapidly and effectively in some areas, and cooperation in the health sciences has been particularly prominent. One of the most important and successful of these has been the Indo-U.S. Vaccine Action Program (VAP), a jointly administered and funded bilateral vaccine research program, which has supported approximately 60 collaborative research projects since its inception in 1987.

“The continued work of the VAP program is an important recognition that vaccines are among the most cost-effective of health technologies and their widespread use in both countries is key to controlling the burden of vaccine-preventable diseases,” states the announcement. “With the emergence of new infectious diseases and increasing attention to health programs which promote child survival, there is renewed interest in attacking this important category of diseases across the full spectrum of scientific, medical and public health disciplines.”  

While applicants should provide evidence of ongoing or proposed scientific collaborations specific to the research proposed in the grant application, this initiative will not require joint application, review and funding of applications by the U.S. and India as was required in previous VAP-supported research projects. Standard NIH/NIAID application and review procedures will be followed. 

Basic, translational, clinical, or epidemiological vaccine research may be proposed under this program.  Further details are available at the National Institutes of Health grants website under: PA-13-179.

From Our Partners
Tags: Avian InfluenzaDengueMalariaTuberculosisVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC